|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/34 | |
| C12N 5/077 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2680864 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12711003.9 |
| Europos patento paraiškos padavimo data | 2012-03-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/050976 |
| Data | 2012-03-01 |
| (87) | Numeris | WO 2012/117373 |
| Data | 2012-09-07 |
| (30) | Numeris | Data | Šalis |
| 201161448712 P | 2011-03-03 | US |
| (72) |
OFFEN, Daniel, IL
DADON-NACHUM, Michal, IL
BEN-ZUR, Tali, IL
MELAMED, Eldad, IL
YAFFE, David, IL
|
| (73) |
Ramot at Tel-Aviv University Ltd.,
P.O. Box 39296, 61392 Tel Aviv,
IL
Yeda Research and Development Co. Ltd., At the Weizmann Institute of Science P.O. Box 95, 76100 Rehovot, IL |
| (54) | GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS |
| GENETICALLY MODIFIED MUSCLE CELLS WHICH EXPRESS NEUROTROPHIC FACTORS |